Search - tctmd.com

Displaying 1 - 20 of 142

Sort: Relevancy | Date

News Daily News

Top Heart Rhythm News of 2024

Todd Neale

December 27, 2024

News Daily News

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

Michael O'Riordan

December 23, 2024

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

Michael O'Riordan

December 18, 2024

News Daily News

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Yael L. Maxwell

December 17, 2024

News Daily News

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Michael O'Riordan

December 06, 2024

News Daily News

EXCEL Data Highlight Bleeding Patterns After CABG, PCI for LM Disease

Yael L. Maxwell

December 05, 2024

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Michael O'Riordan

December 02, 2024

News Conference News PCR London Valves 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

News Daily News

Closing the Left Atrial Septal Pouch For Stroke Prevention Explored in Small Trial

Todd Neale

November 25, 2024

News Conference News AHA 2024

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Michael O'Riordan

November 21, 2024

News Conference News AHA 2024

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

Todd Neale

November 18, 2024

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan

November 16, 2024

News Conference News AHA 2024

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

Shelley Wood

November 16, 2024

News Conference News VIVA 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

L.A. McKeown

November 14, 2024

News Conference News TCT 2024

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Caitlin E. Cox

November 08, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

Advertisement

Top Heart Rhythm News of 2024

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

December 2024 Dispatch for the CV Team

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

EXCEL Data Highlight Bleeding Patterns After CABG, PCI for LM Disease

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Closing the Left Atrial Septal Pouch For Stroke Prevention Explored in Small Trial

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content